| Cynthia G Chrobak, DO | |
|
789 Central Ave, Wentworth-douglass Hospital, Dover, NH 03820 | |
| (603) 749-7246 | |
| (603) 749-2453 |
| Full Name | Cynthia G Chrobak |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 23 Years |
| Location | 789 Central Ave, Dover, New Hampshire |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447237888 | NPI | - | NPPES |
| 30223835 | Medicaid | NH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 12836 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wentworth-douglass Hospital | Dover, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wentworth Douglass Physician Corporation | 5496749848 | 372 |
News Archive
Patients who discuss their coronary risk profiles with their physicians may respond better to treatment for cholesterol disorders, according to a report in the November 26 issue of Archives of Internal Medicine.
The first data to show that Neupro® (rotigotine transdermal system) significantly improved wellbeing and daily activities that are often impaired by pain related to Restless Legs Syndrome (RLS) were presented this week at the 14th International Congress of Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
A new study conducted by the Center for Injury Research and Policy of The Research Institute at Nationwide Children's Hospital found that from 1997-2007, an estimated 229,023 children and adolescents younger than 19 years were treated in U.S. hospital emergency departments for sledding-related injuries, an average of more than 20,000 cases each year.
AstraZeneca today announced that the European Commission (EC) has granted conditional marketing authorisation for TAGRISSO™ (AZD9291, osimertinib) 80mg once-daily tablets for the treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC).
› Verified 9 days ago
| Entity Name | North American Partners In Anesthesia New Hampshire Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306838701 PECOS PAC ID: 6901710946 Enrollment ID: O20031114000273 |
News Archive
Patients who discuss their coronary risk profiles with their physicians may respond better to treatment for cholesterol disorders, according to a report in the November 26 issue of Archives of Internal Medicine.
The first data to show that Neupro® (rotigotine transdermal system) significantly improved wellbeing and daily activities that are often impaired by pain related to Restless Legs Syndrome (RLS) were presented this week at the 14th International Congress of Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
A new study conducted by the Center for Injury Research and Policy of The Research Institute at Nationwide Children's Hospital found that from 1997-2007, an estimated 229,023 children and adolescents younger than 19 years were treated in U.S. hospital emergency departments for sledding-related injuries, an average of more than 20,000 cases each year.
AstraZeneca today announced that the European Commission (EC) has granted conditional marketing authorisation for TAGRISSO™ (AZD9291, osimertinib) 80mg once-daily tablets for the treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC).
› Verified 9 days ago
| Entity Name | Anesthesia Care Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629074224 PECOS PAC ID: 5395646178 Enrollment ID: O20040115000446 |
News Archive
Patients who discuss their coronary risk profiles with their physicians may respond better to treatment for cholesterol disorders, according to a report in the November 26 issue of Archives of Internal Medicine.
The first data to show that Neupro® (rotigotine transdermal system) significantly improved wellbeing and daily activities that are often impaired by pain related to Restless Legs Syndrome (RLS) were presented this week at the 14th International Congress of Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
A new study conducted by the Center for Injury Research and Policy of The Research Institute at Nationwide Children's Hospital found that from 1997-2007, an estimated 229,023 children and adolescents younger than 19 years were treated in U.S. hospital emergency departments for sledding-related injuries, an average of more than 20,000 cases each year.
AstraZeneca today announced that the European Commission (EC) has granted conditional marketing authorisation for TAGRISSO™ (AZD9291, osimertinib) 80mg once-daily tablets for the treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC).
› Verified 9 days ago
| Entity Name | Wentworth Douglass Physician Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447352430 PECOS PAC ID: 5496749848 Enrollment ID: O20040409000433 |
News Archive
Patients who discuss their coronary risk profiles with their physicians may respond better to treatment for cholesterol disorders, according to a report in the November 26 issue of Archives of Internal Medicine.
The first data to show that Neupro® (rotigotine transdermal system) significantly improved wellbeing and daily activities that are often impaired by pain related to Restless Legs Syndrome (RLS) were presented this week at the 14th International Congress of Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
A new study conducted by the Center for Injury Research and Policy of The Research Institute at Nationwide Children's Hospital found that from 1997-2007, an estimated 229,023 children and adolescents younger than 19 years were treated in U.S. hospital emergency departments for sledding-related injuries, an average of more than 20,000 cases each year.
AstraZeneca today announced that the European Commission (EC) has granted conditional marketing authorisation for TAGRISSO™ (AZD9291, osimertinib) 80mg once-daily tablets for the treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cynthia G Chrobak, DO Po Box 1433, Atlantic Anesthesia Pa, Dover, NH 03821-1433 Ph: (603) 749-7246 | Cynthia G Chrobak, DO 789 Central Ave, Wentworth-douglass Hospital, Dover, NH 03820 Ph: (603) 749-7246 |
News Archive
Patients who discuss their coronary risk profiles with their physicians may respond better to treatment for cholesterol disorders, according to a report in the November 26 issue of Archives of Internal Medicine.
The first data to show that Neupro® (rotigotine transdermal system) significantly improved wellbeing and daily activities that are often impaired by pain related to Restless Legs Syndrome (RLS) were presented this week at the 14th International Congress of Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.
A new study conducted by the Center for Injury Research and Policy of The Research Institute at Nationwide Children's Hospital found that from 1997-2007, an estimated 229,023 children and adolescents younger than 19 years were treated in U.S. hospital emergency departments for sledding-related injuries, an average of more than 20,000 cases each year.
AstraZeneca today announced that the European Commission (EC) has granted conditional marketing authorisation for TAGRISSO™ (AZD9291, osimertinib) 80mg once-daily tablets for the treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC).
› Verified 9 days ago
Dr. Dennis B. Thapa, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 789 Central Ave, Dover, NH 03820 Phone: 603-609-6819 Fax: 603-609-6821 | |
Dr. Sargis Ohanyan, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 789 Central Ave, Dover, NH 03820 Phone: 603-609-6819 | |
Dr. Ira Seth Lehrer, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 789 Central Ave, Dover, NH 03820 Phone: 603-749-7246 Fax: 603-749-2453 | |
James M Mckenna, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 789 Central Ave, Wentworth Douglass Hospital, Dover, NH 03820 Phone: 603-749-7246 Fax: 603-749-2453 | |
Dr. Robert F. O'donnell, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 789 Central Ave, Dover, NH 03820 Phone: 603-742-5252 | |
Dr. Christopher John Curatolo, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 789 Central Ave, Dover, NH 03820 Phone: 603-742-5252 | |
Thomas Zouki, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 789 Central Ave, Dover, NH 03820 Phone: 603-609-6819 Fax: 603-609-6821 |